TABLE 2: Recovery of ibuprofen, ibuprofen 2-hydroxyethyl ester, and codrug in human plasma and rat liver homogenate
QC Recovery Samples Human plasma, n = 3 Compound
Ibuprofen
Ibuprofen 2-hydroxyethyl ester
Codrug
Nominal concentration (µg mL-1 25
100 25
100 25
100
Rat liver homogenate, n = 3 Compound
Ibuprofen
Ibuprofen 2-hydroxyethyl ester
Codrug
100 25
100 25
100 0.195 - 400 µg mL-1
Nominal concentration (µg mL-1 25
) )
Recovered concentration (µg mL-1 24.4 96.9 24.2 98.2 23.9 98.2
Recovered concentration (µg mL-1 25.1
100.1 24.8 99.6 24.9 99.5
; indicating excellent linearity. The limits of
detection were between 20 and 24 ng mL-1 were between 60 and 80 ng mL-1
and LOQ = 60 ng mL-1 and limits for quantification . The linear regression equations
for IBP, its ester, and codrug in addition to the limits of detection and quantification are as follows: IBP, y = (28179)x + (40185), R2 LOD = 20 ng mL-1
y = (17230)x + (58266), R2 = 65 ng mL-1
(23400)x + (27671), R2 ng mL-1
.
Accuracy and precision Table 1 shows the intra-assay and inter-assay variability results. The RSD (%) values for IBP, IBP 2-hydroxyethyl ester, and codrug were determined and were less than the maximum allowed limit; % RSD ≤ 1.0% for intra-day precision and ≤ 2% for inter-day precision. This confirms the intra-day and inter-day reproducibility and accuracy of the developed HPLC method across the chosen four concentrations for the three former compounds.
Recovery Recovery for IBP, IBP 2-hydroxyethyl ester, and codrug from human plasma and rat liver homogenate was assessed (n = 3) at 25 and 100 µg mL-1
. As shown in table 2, the recovery for IBP, IBP 2-hydroxyethyl
ester, and codrug were more than 95%, in human plasma and more than 99% in rat liver homogenate. The high plasma recovery for IBP, its ester, and its codrug suggests negligible loss of each of the aforementioned compounds during protein precipitation process using methanol, similarly the extraction efficiency of the intended compounds in rat liver homogenate was greatly efficient as the former.
FIGURE 1: The chemical structures of ibuprofen, ibuprofen 2-hydroxyethyl ester, and ibuprofen-nicotinic acid codrug
OR OR
OO
Ibuprofen 2-hydroxyethyl ester and nicotinic acid codrug, R’’= Ibuprofen 2-hydroxyethyl ester and nicotinic acid codrug, R'' =
Ibuprofen 2-hydroxyethyl ester, R’= OH Ibuprofen 2-hydroxyethyl ester and nicotinic acid codrug, R'' =
Ibuprofen, R= H Ibuprofen, R=H Ibuprofen 2-hydroxyethyl ester, R' = Ibuprofen 2-hydroxyethyl ester, R' = 040 MEDLAB MAGAZINE ISSUE 1 2012 OH O N OH O O N O Ibuprofen, R= H = 0.9999, LOD = 20 ng mL-1
, IBP 2-hydroxyethyl ester - nicotinic acid codrug, y = = 0.9999, LOD = 24 ng mL-1
= 0.9999,
, IBP 2-hydroxyethyl ester, and LOQ
and LOQ = 80 40
35 30 25 20
15 10 5 0
-5 0 1 2 3 4 5 6 Time (min) 40
35 30 25 20
15 10 5 0
-5 0 1 2 3 4 5 6 Time (min) 40
35 30 25 20
15 10 5 0
-5 0 1 2 3 4 5 6 Time (min) 7 8 9 10 C 7 8 9 10 B 7 8 9 10 A )
Standard deviation (µg mL-1 0.68 2.62 0.55 1.38 0.47 1.72
)
Standard deviation (µg mL-1 0.05 0.12 0.19 0.03
0.15 0.23
) Recovery (%) RSD (%) 2.78 2.71 2.27 1.41 1.97 1.75
97.7 96.9 96.8 98.2 95.4 98.2
) Recovery (%) RSD (%) 0.18 0.12 0.78 0.03 0.59 0.23
100.2 100.1 99.1 99.6 99.5 99.5
FIGURE 2: HPLC chromatogram of ibuprofen, ibuprofen 2-hydroxyethyl ester, and codrug from stability study in (a) aqueous solution, (b) human plasma, (c) rat liver homogenate
mAU
mAU
mAU
Ibuprofen 2-hydroxyethyl Ester Ibuprofen 2-hydroxyethyl Ester Ibuprofen 2-hydroxyethyl Ester Ibuprofen
Ibuprofen
Ibuprofen
Codrug Codrug
Codrug
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44